Ioannis Boletis
Overview
Explore the profile of Ioannis Boletis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marinaki S, Kompotiatis P, Michelakis I, Stangou M, Papagianni A, Koukoulaki M, et al.
PLoS One
. 2024 Dec;
19(12):e0315124.
PMID: 39693288
Background/objective: Primary Focal and Segmental glomerulosclerosis (FSGS) is one of the most common causes of idiopathic nephrotic syndrome. Our aim was to describe a large cohort of patients with primary...
2.
Gompou A, Perrea D, Karatzas T, Kastania A, Dimaki A, Xydias E, et al.
Cureus
. 2024 Dec;
16(11):e73185.
PMID: 39650936
Introduction Interleukin-2 (IL-2) is a cytokine that exerts its actions via binding to a variety of interleukin-2 receptors (IL-2R), thereby stimulating T-cell response. Acute renal graft rejection (AR) is known...
3.
Lionaki S, Kriki P, Marinaki S, Gkalitsiou D, Dounousi E, Liakopoulos V, et al.
Kidney Int Rep
. 2024 Nov;
9(11):3324-3327.
PMID: 39534188
No abstract available.
4.
Lionaki S, Dounousi E, Marinaki S, Kantartzi K, Papasotiriou M, Galitsiou D, et al.
Front Nephrol
. 2024 Nov;
4:1472294.
PMID: 39497750
Introduction: This study aimed to describe the clinical course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with glomerular diseases (GDs) and its impact on the probability...
5.
Angelousi A, Liapis G, Gazouli M, Kofotolios I, Sakellariou S, Boletis I, et al.
Mol Med Rep
. 2023 Jul;
28(3).
PMID: 37477126
Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and...
6.
Athanasopoulou D, Lionaki S, Skalioti C, Liapis G, Vlachoyiannopoulos P, Boletis I
Life (Basel)
. 2023 Jun;
13(6).
PMID: 37374047
Kidney injury due to medications is a well-known clinical entity. Although drug-induced tubulointerstitial disease is commonly encountered, there are few reports in the literature associated with glomerular injury due to...
7.
Johnston-Webber C, Prionas A, Wharton G, Streit S, Mah J, Boletis I, et al.
Transpl Int
. 2023 Jun;
36:11013.
PMID: 37305340
Greece has fallen far behind many comparable European countries in the field of organ donation and transplantation and has made little progress over the past decade. Despite efforts to improve...
8.
Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann C, Bistola V, et al.
Eur J Heart Fail
. 2023 Mar;
25(6):818-828.
PMID: 36974770
Aim: Evidence on healthcare resource utilization (HCRU) for hospitalized patients with heart failure (HF) and reduced (HFrEF), mildly reduced (HFmrEF) and preserved (HFpEF) ejection fraction is limited. Methods And Results:...
9.
Tsoulfas G, Boletis I, Papalois V
World J Transplant
. 2023 Mar;
13(2):25-27.
PMID: 36908305
The continuous clinical and technological advances, together with the social, health and economic challenges that the global population faces, have created an environment where the evolution of the field of...
10.
Alexandrou M, Ferro C, Boletis I, Papagianni A, Sarafidis P
World J Transplant
. 2022 Sep;
12(8):211-222.
PMID: 36159073
Kidney transplantation is considered the treatment of choice for end-stage kidney disease patients. However, the residual cardiovascular risk remains significantly higher in kidney transplant recipients (KTRs) than in the general...